[EN] BICYCLIC HETEROCYCLES AS HIV INTEGRASE INHIBITORS<br/>[FR] HETEROCYCLES BICYCLIQUES EN TANT QU'INHIBITEURS DE L'INTEGRASE DU VIH
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2007064316A1
公开(公告)日:2007-06-07
[EN] The invention encompasses a series cyclic bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV. [FR] L'invention concerne une série de composés cycliques de pyrimidinone bicyclique de formule I constituant des inhibiteurs de l'intégrase du VIH et permettant d'empêcher l'intégration virale dans l'ADN humain. Cette action rend ces composés utiles pour le traitement des infections VIH et du SIDA. L'invention concerne également des compositions pharmaceutiques et des procédés de traitement des patients infectés au VIH.
Palladium-Catalysed CH Bond Electrophilic Fluorination of Highly Substituted Arylpyrazoles: Experimental and DFT Mechanistic Insights
A general protocol for palladium‐catalysed CH mono‐ and di‐fluorination of highly substituted arylpyrazoles is reported. Coupling pathways and substrate limitations are discussed in the light of complementary mechanistic experimental and density functional theory (DFT) studies. The mono‐ and di‐ortho‐fluorination of arylpyrazoles having substituted pyrazole groups and ortho‐, meta‐, or para‐substituted